Autres langues Amgen Inc.

Actions

AMGN

US0311621009

Produits pharmaceutiques

Temps réel estimé Cboe BZX Autres places de cotation 17:50:13 27/07/2026			Varia. 5j.	Varia. 1 janv.
378,37 ^USD	+0,62%		+3,95%	+15,66%

15:19	Sarepta nomme l'ancien président d'AbbVie au poste de PDG pour succéder à Doug Ingram	RE
13:18	Le laboratoire chinois Innocare annonce un " effet thérapeutique constant » pour son traitement oral contre le psoriasis en phase finale d'essai	RE

Autres langues

15:19	Sarepta names former Abbvie president as CEO as Ingram retires
13:18	China's Innocare says psoriasis oral drug shows 'consistent treatment effect' in late-stage trial
08:17	Protecting Antibody Innovations Beyond Composition Claims
24/07	Amgen submits new data to challenge FDA's proposal to withdraw Tavneos
24/07	WOCHENVORSCHAU/3. August bis 9. August 2026 (32. KW)
24/07	Unternehmenskalender vom 27. bis 31. Juli 2026
24/07	Amgen : Statement on FDA Data Submission for TAVNEOS® (avacopan)
24/07	CuraTeQ Biologics Wins European Medicines Agency's Positive Opinion for Neulasta Biosimilar
22/07	Amgen Reportedly to Pay $74 Million to Settle Shareholder Suit Over Delayed IRS Tax Disclosure
21/07	Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill
17/07	Gestern an der Wall Street: Halbleitersektor belastet die Börsen
17/07	Ayer en Wall Street: los semiconductores lastran el cierre de la jornada
16/07	Merck & Co erhält US-Zulassung für neuartige Cholesterin-Pille
16/07	Merck gets US FDA nod for first-in-its-class oral cholesterol drug
08/07	Amgen Ecovation®: How Amgen Builds Sustainability Into Biotech
08/07	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
07/07	Weight-loss drug developers line up to tap lucrative market as competition heats up
04/07	Amgen Inc. Announces Product Recall
04/07	Amgen, Inc. Announces Product Recall
04/07	Amgen Inc Recalls Sensipar Tablets 30 mg, 30-Count Bottles Due to CGMP Deviations
04/07	Amgen Inc Announces Product Recall
04/07	Amgen Recalls Corlanor Tablets Due to Presence of Foreign Substance
03/07	Regeneron gegen Amgen: Eylea mitten im Ring
02/07	Amgen Wins Preliminary Injunction to Block Colorado From Imposing Price Cap on Arthritis Drug
02/07	Regeneron frente a Amgen: Eylea en el centro del ring